Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Néoplasie

02. Novembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3671


	Articles 1 - 20 / 73414

	Clinicopathological significance of AKT and phosphorylated AKT expression in hepatocellular carcinoma: A Meta-Analysis. BMC Cancer Ma Y, Chen M, Xu Z. PMID: 41174612 [PubMed - indexed for MEDLINE]
	Efficacy and safety of DEB-TACE combined with HAIC and donafenib in the treatment of unresectable hepatocellular carcinoma: a dual-center retrospective study. BMC Cancer Zhang X, Fang X, Wang R, Xiong B, Long J, Guo Q, Chu M, Luo W, Shi S. PMID: 41174543 [PubMed - indexed for MEDLINE]
	A Higher Risk of Liver Cancer in Alcoholic Fatty Liver Disease than in Non-Alcoholic Fatty Liver Disease: an Analysis of the TriNetX Dabatase. J Gastrointest Cancer Chang LH, Su SY, Lee C, Hsu CY. PMID: 41171519 [PubMed - indexed for MEDLINE]
	Chemoprevention of hepatocellular carcinoma. Hepatol Commun Schwenk S, Kaplan DE. PMID: 41171441 [PubMed - indexed for MEDLINE]
	Development and evaluation of a nutritional risk prediction model for patients with hepatocellular carcinoma undergoing transarterial chemoembolisation. Clin Exp Med Chen CX, Chen XF, Wang TL, Gu HY, Xu GH, Cui ZM. PMID: 41171346 [PubMed - indexed for MEDLINE]
	First-line immune checkpoint inhibitors plus targeted therapy versus sorafenib or lenvatinib monotherapy for unresectable or advanced hepatocellular carcinoma: a meta-analysis of phase 3 trials. Front Immunol Lin Y, Liao Y, Luo B, Shen J. PMID: 41169385 [PubMed - indexed for MEDLINE]
	Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma. Front Immunol Zhong F, Yao F, Wang XL, Wang Z, Huang B, Liu J, Wang X, Zhang L. PMID: 41169384 [PubMed - indexed for MEDLINE]
	Immunological aspects of naturally occurring model of hepatitis B virus (HBV) infection, hepatitis B, and HBV-associated hepatocellular carcinoma in the American woodchuck Marmota monax. J Immunol Michalak TI. PMID: 41169234 [PubMed - indexed for MEDLINE]
	Epidemiological Profile of Hepatocellular Carcinoma in Brazil. In Vivo DA Rocha RR, Martins MR, DE Melo LWP, Dos Santos RL, Torres LC, Thuler LCS, Costa GJ. PMID: 41167688 [PubMed - indexed for MEDLINE]
	Nanomaterial-assisted immunodiagnostic profiling and therapeutic targeting of hepatocellular carcinoma: from molecular biomarkers to clinical applications. Front Immunol Luo J, Ye J, Huang K, Cheng Z, Liu L, Li X. PMID: 41164201 [PubMed - indexed for MEDLINE]
	Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk. Front Immunol Ma Z, Wang S, Liu S, Yang W, Hu J, Lv L, Yu Q, Lu Y. PMID: 41164182 [PubMed - indexed for MEDLINE]
	Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study. Eur J Med Res Bi F, Qin S, Gu S, Bai Y, Chen Z, Wang Z, Ying J, Lu Y, Meng Z, Pan H, Yang P, Zhang H, Chen X, Xu A, Cui C, Zhu B, Wu J, Xin X, Wang J, Shan J, Chen J, Zheng Z, Xu L, Wen X, You Z, Ren Z, Xu J, Du C, Fan Q, Zhang L, Tao M, Jiang D, Wang S, Chen Y, Sheng J, Zhuang X, Wu J. PMID: 41163129 [PubMed - indexed for MEDLINE]
	The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study. J Hematol Oncol Guo D, Huang A, Sun J, Zhang S, Cheng J, Jiang R, Wang Y, Chen H, Zhang F, Peng J, Yuan J, Wang J, Guo H, Chen Z, Chen Y, Chen X, Zhu S, Fan J, Wang Y, Yang X, Zhou J. PMID: 41163059 [PubMed - indexed for MEDLINE]
	The Ubiquitin-Proteasome System in Hepatitis B Virus Infection and Hepatocarcinogenesis: Viral Manipulation and Therapeutic Targets. J Microbiol Biotechnol Han J, Kim KH, Seo SU. PMID: 41162171 [PubMed - indexed for MEDLINE]
	Ultrasounic-radiomics models for predicting the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma. PLoS One Li Y, Liu Z, Qian Y, Wang K, Gu Y, Chen Y, Jiang H, Cheng S, Jiang D. PMID: 41160615 [PubMed - indexed for MEDLINE]
	Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastases. Cancer Metastasis Rev Cunanan CJ, Sanders AB, Gallant KC, Seedor RS, Hartsough EJ. PMID: 41160198 [PubMed - indexed for MEDLINE]
	Machine learning algorithms for individualized prediction of prognosis in breast cancer liver metastases and the prognostic impact of primary tumor surgery: a multicenter study. Front Endocrinol (Lausanne) Chen C, Wu J, Xu B, Li W, Zhong C, Yan Z, Zhong Q, Li R, Shao M, Dong Y, Fang Y, Li Y, Zhang Q. PMID: 41158637 [PubMed - indexed for MEDLINE]
	Research Progress on Quinone Compounds for the Treatment of Hepatocellular Carcinoma. Biomolecules Ye Y, Liu M, Miao Y, Pei K, Lin Z, Liu S, Huang X, Wang Y, Lv G. PMID: 41154629 [PubMed - indexed for MEDLINE]
	Effect of disappearing liver metastases during pre-ablation chemotherapy on the prognosis of percutaneous microwave ablation in synchronous colorectal liver metastases patients. Cancer Imaging Chen L, Zhou J, Cui R, Qin S, Chen Y, Wang Y, Liu G. PMID: 41153064 [PubMed - indexed for MEDLINE]
	The interplay between hepatitis B virus and antitumor drugs in the treatment of hepatocellular carcinoma. Clin Exp Med Ma T, Zhao F, Yao L, Mao C, Tian Y, Ma Y, Kong F, Liu R. PMID: 41152543 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 73414

Page 1 de 3671



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité